Pinnacle Associates’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-214,014
| Closed | -$18.2M | – | 748 |
|
|
2019
Q4 | $18.2M | Sell |
214,014
-229,580
| -52% | -$15.3M | 0.4% | 73 |
|
|
2019
Q3 | $22.2M | Sell |
443,594
-115,906
| -21% | -$4.62M | 0.52% | 54 |
|
|
2019
Q2 | $20.4M | Sell |
559,500
-150,492
| -21% | -$4.91M | 0.48% | 56 |
|
|
2019
Q1 | $19.8M | Sell |
709,992
-3,760
| -0.5% | -$88.6K | 0.45% | 63 |
|
|
2018
Q4 | $13.7M | Sell |
713,752
-102,792
| -13% | -$2.39M | 0.35% | 81 |
|
|
2018
Q3 | $24.4M | Sell |
816,544
-129,068
| -14% | -$4.86M | 0.51% | 54 |
|
|
2018
Q2 | $34.7M | Sell |
945,612
-157,775
| -14% | -$5.13M | 0.71% | 40 |
|
|
2018
Q1 | $36.3M | Sell |
1,103,387
-63,754
| -5% | -$1.99M | 0.71% | 39 |
|
|
2017
Q4 | $31.9M | Sell |
1,167,141
-94,030
| -7% | -$2.9M | 0.61% | 47 |
|
|
2017
Q3 | $46.7M | Sell |
1,261,171
-11,965
| -0.9% | -$441K | 0.86% | 25 |
|
|
2017
Q2 | $48.4M | Sell |
1,273,136
-44,970
| -3% | -$2M | 0.93% | 24 |
|
|
2017
Q1 | $64.5M | Sell |
1,318,106
-60,186
| -4% | -$2.74M | 1.23% | 16 |
|
|
2016
Q4 | $46.8M | Buy |
1,378,292
+426,978
| +45% | +$15.1M | 0.94% | 24 |
|
|
2016
Q3 | $35.9M | Sell |
951,314
-18,673
| -2% | -$704K | 0.72% | 34 |
|
|
2016
Q2 | $32.6M | Sell |
969,987
-7,340
| -0.8% | -$259K | 0.7% | 34 |
|
|
2016
Q1 | $31.1M | Buy |
977,327
+294,280
| +43% | +$9.61M | 0.66% | 38 |
|
|
2015
Q4 | $25.5M | Sell |
683,047
-36,352
| -5% | -$1.37M | 0.54% | 48 |
|
|
2015
Q3 | $27.3M | Sell |
719,399
-48,355
| -6% | -$1.7M | 0.6% | 49 |
|
|
2015
Q2 | $22M | Buy |
767,754
+309,550
| +68% | +$8.62M | 0.41% | 69 |
|
|
2015
Q1 | $12.8M | Sell |
458,204
-9,071
| -2% | -$255K | 0.24% | 102 |
|
|
2014
Q4 | $12.9M | Sell |
467,275
-5,344
| -1% | -$132K | 0.25% | 100 |
|
|
2014
Q3 | $10.5M | Sell |
472,619
-195,155
| -29% | -$4.96M | 0.21% | 119 |
|
|
2014
Q2 | $19.4M | Sell |
667,774
-41,750
| -6% | -$1.12M | 0.38% | 74 |
|
|
2014
Q1 | $20.2M | Buy |
709,524
+11,329
| +2% | +$375K | 0.39% | 71 |
|
|
2013
Q4 | $27M | Sell |
698,195
-13,171
| -2% | -$471K | 0.53% | 50 |
|
|
2013
Q3 | $23.8M | Sell |
711,366
-8,106
| -1% | -$258K | 0.49% | 59 |
|
|
2013
Q2 | $22.1M | Buy |
+719,472
| New | +$24.1M | 0.5% | 58 |
|
Other funds holding MDCO
Pinnacle Associates's MDCO Position: Q1 2020 in Review
Pinnacle Associates sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 214,014 shares — an estimated $18.2M sold.
Pinnacle Associates first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $64.5M in Q1 2017. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Pinnacle Associates reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Pinnacle Associates sold 214,014 Medicines Co shares in Q1 2020, an estimated $18.2M.
- Pinnacle Associates first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Pinnacle Associates's Medicines Co position peaked at $64.5M in Q1 2017.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Pinnacle Associates's 13F filing for Q1 2020, filed 13 May 2020.